Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quest Diagnostics/Unilab

This article was originally published in The Gray Sheet

Executive Summary

Lab testing firms remain committed to merger pact despite Federal Trade Commission antitrust concerns that will necessitate the divestiture of certain assets in northern California. Quest agreed to buy Unilab for about $1.1 bil. in cash and stock in April, but proposed changes would reduce the value of the deal by about $60 mil. Discussions are ongoing for a potential asset sale to a third party, amendment of the merger deal and extension of the merger expiration date to Jan. 31 (1"The Gray Sheet" April 8, 2002, p. 19)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel